Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate
      Health

      Emergent BioSolutions Initiates Phase 1 Study Evaluating Lassa Virus Vaccine Candidate

      September 6, 2022
      Tonix Pharmaceuticals Announces Oral Presentations Involving TNX-1500 (Fc-Modified Anti-CD40L mAb) at the International Congress of The Transplantation Society (TTS 2022)
      Health

      Tonix Pharmaceuticals Announces Oral Presentations Involving TNX-1500 (Fc-Modified Anti-CD40L mAb) at the International Congress of The Transplantation Society (TTS 2022)

      September 6, 2022
      Astellas Announces Topline Results from Phase 3 Long-Term Safety Study of Fezolinetant in Mainland China
      Health

      Astellas Announces Topline Results from Phase 3 Long-Term Safety Study of Fezolinetant in Mainland China

      September 5, 2022
      Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports
      Health

      Over 480 Million People Estimated to Have COPD, World’s Third Deadliest Disease, ResMed Study Reports

      September 5, 2022
      Akebia Therapeutics to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference
      Health

      Akebia Therapeutics to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference

      September 2, 2022
      GeoVax Announces Addition to Its Board of Directors
      Health

      GeoVax Announces Addition to Its Board of Directors

      September 2, 2022
      EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna’s Omicron-Targeting Bivalent Booster in the European Union
      Health

      EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna’s Omicron-Targeting Bivalent Booster in the European Union

      September 2, 2022
      Comera Life Sciences Announces Up To $15 million Purchase Agreement with Arena Business Solutions
      Health

      Comera Life Sciences Announces Up To $15 million Purchase Agreement with Arena Business Solutions

      September 1, 2022
      CENTENE CORPORATION APPOINTS ASHLEE KNUCKEY AS CHIEF ETHICS AND COMPLIANCE OFFICER
      Health

      CENTENE CORPORATION APPOINTS ASHLEE KNUCKEY AS CHIEF ETHICS AND COMPLIANCE OFFICER

      September 1, 2022
      CooperCompanies Announces Third Quarter 2022 Results
      Health

      CooperCompanies Announces Third Quarter 2022 Results

      September 1, 2022
      « 1 … 236 237 238 239 240 … 256 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026